E-LIB Suche - Ergebnisse für: Morales, Serafin

1

Single-agent metronomic versus weekly oral vinorelbine as f..:

Freyer, Gilles ; Martinez-Jañez, Noelia ; Kukielka-Budny, Bożena...
The Breast. 74 (2024) - p. 103681 , 2024

Link: https://doi.org/10.1016/..

2

Olaparib plus trastuzumab in HER2-positive advanced breast ..:

Alés-Martínez, José Enrique ; Balmaña, Judith ; Sánchez-Rovira, Pedro...
The Breast. 77 (2024) - p. 103780 , 2024

Link: https://doi.org/10.1016/..

3

Targeted Next Generation Sequencing of a Custom Capture Pan..:

, In: Bioinformatics and Biomedical Engineering; Lecture Notes in Computer Science,

Benítez, Iván ; Urdanibia, Izaskun ; Matias-Guiu, Xavier... - p. 137-150 , 2023

Link: https://doi.org/10.1007/..

4

XENERA-1: a randomised double-blind Phase II trial of xentu..:

Schmid, Peter ; Cortes, Javier ; Joaquim, Ana...
Breast Cancer Research. 25 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

5

Applications of CRISPR Technology to Breast Cancer and Trip..:

Pont, Mariona ; Marqués, Marta ; Sorolla, Maria Alba...
Cancers. 15 (2023) 17 - p. 4364 , 2023

Link: https://doi.org/10.3390/..

6

Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathologica..:

Ocaña, Alberto ; Chacón, Jose Ignacio ; Calvo, Lourdes...
Frontiers in Oncology. 11 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

7

Overall survival with palbociclib plus endocrine therapy ve..:

Martín, Miguel ; Zielinski, Christoph ; Ruiz-Borrego, Manuel...
European Journal of Cancer. 168 (2022) - p. 12-24 , 2022

Link: https://doi.org/10.1016/..

8

Are Transcription Factors Plausible Oncotargets for Triple ..:

Marqués, Marta ; Sorolla, Maria Alba ; Urdanibia, Izaskun...
Cancers. 14 (2022) 5 - p. 1101 , 2022

Link: https://doi.org/10.3390/..

9

Health-related quality of life with palbociclib plus endocr..:

Kahan, Zsuzsanna ; Gil-Gil, Miguel ; Ruiz-Borrego, Manuel...
European Journal of Cancer. 156 (2021) - p. 70-82 , 2021

Link: https://doi.org/10.1016/..

10

Long-Term Cardiac Safety and Survival Outcomes of Neoadjuva..:

Gil-Gil, Miguel J. ; Bellet, Meritxell ; Bergamino, Milana...
Frontiers in Oncology. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

11

A phase Ib/II study of xentuzumab, an IGF-neutralising anti..:

Schmid, Peter ; Sablin, Marie-Paule ; Bergh, Jonas...
Breast Cancer Research. 23 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

12

Phase I/II study to assess the clinical pharmacology and sa..:

Yao, Hsuan-Ming ; Jones, Sarah Ruta ; Morales, Serafin...
Cancer Chemotherapy and Pharmacology. 88 (2021) 6 - p. 1033-1048 , 2021

Link: https://doi.org/10.1007/..

13

Her2-Positive Cancers and Antibody-Based Treatment: State o..:

Morales, Serafin ; Gasol, Ariadna ; Sanchez, Douglas Rene
Cancers. 13 (2021) 22 - p. 5771 , 2021

Link: https://doi.org/10.3390/..

14

Neoadjuvant eribulin in HER2-negative early-stage breast ca..:

Pascual, Tomás ; Oliveira, Mafalda ; Villagrasa, Patricia...
npj Breast Cancer. 7 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

15

Palbociclib combined with endocrine therapy in heavily pret..:

Manso, Luis ; Hernando, Cristina ; Galán, María...
The Breast. 54 (2020) - p. 286-292 , 2020

Link: https://doi.org/10.1016/..